Arcadia Biosciences (NASDAQ:RKDA) vs. Oriental Rise Holdings Limited Ordinary Shares (NASDAQ:ORIS) Critical Review

Arcadia Biosciences (NASDAQ:RKDA) and Oriental Rise Holdings Limited Ordinary Shares (NASDAQ:ORIS) are both small-cap basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations and institutional ownership.

Institutional & Insider Ownership

17.7% of Arcadia Biosciences shares are held by institutional investors. 1.8% of Arcadia Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Arcadia Biosciences and Oriental Rise Holdings Limited Ordinary Shares’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Arcadia Biosciences	-110.61%	-52.63%	-34.57%
Oriental Rise Holdings Limited Ordinary Shares	N/A	N/A	N/A

Analyst Ratings

This is a summary of recent ratings and recommmendations for Arcadia Biosciences and Oriental Rise Holdings Limited Ordinary Shares, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arcadia Biosciences	0	0	1	1	3.50
Oriental Rise Holdings Limited Ordinary Shares	0	0	0	0	0.00

Arcadia Biosciences presently has a consensus target price of $6.00, suggesting a potential downside of 5.66%. Given Arcadia Biosciences’ stronger consensus rating and higher probable upside, analysts clearly believe Arcadia Biosciences is more favorable than Oriental Rise Holdings Limited Ordinary Shares.

Earnings & Valuation

This table compares Arcadia Biosciences and Oriental Rise Holdings Limited Ordinary Shares”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arcadia Biosciences	$5.48 million	1.58	-$13.98 million	($4.28)	-1.49
Oriental Rise Holdings Limited Ordinary Shares	$16.75 million	2.78	$11.50 million	N/A	N/A

Oriental Rise Holdings Limited Ordinary Shares has higher revenue and earnings than Arcadia Biosciences.

About Arcadia Biosciences

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

About Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Limited engages in planting, cultivating, processing, and selling processed tea in Mainland China. It offers processed white tea, black tea, and refined tea products to wholesale distributors and end-user retail customers. The company was incorporated in 2019 and is based in Ningde, China.